ECSP066909A - Ascorbato de bazedoxifeno como modulador del receptor de estrogeno selectivo - Google Patents

Ascorbato de bazedoxifeno como modulador del receptor de estrogeno selectivo

Info

Publication number
ECSP066909A
ECSP066909A EC2006006909A ECSP066909A ECSP066909A EC SP066909 A ECSP066909 A EC SP066909A EC 2006006909 A EC2006006909 A EC 2006006909A EC SP066909 A ECSP066909 A EC SP066909A EC SP066909 A ECSP066909 A EC SP066909A
Authority
EC
Ecuador
Prior art keywords
ascorbate
bazedoxifen
strogen
selective
receiver modulator
Prior art date
Application number
EC2006006909A
Other languages
English (en)
Inventor
Kadum Abdul Nabi Ali
Mahdi Bakir Fawzi
Syed M Shah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP066909A publication Critical patent/ECSP066909A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invención está dirigida a ascorbato de bazedoxifeno, composiciones que contienen el mismo, dispersiones del mismo, preparaciones del mismo y usos del mismo.
EC2006006909A 2004-04-08 2006-10-06 Ascorbato de bazedoxifeno como modulador del receptor de estrogeno selectivo ECSP066909A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56045404P 2004-04-08 2004-04-08

Publications (1)

Publication Number Publication Date
ECSP066909A true ECSP066909A (es) 2006-12-20

Family

ID=34964936

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006909A ECSP066909A (es) 2004-04-08 2006-10-06 Ascorbato de bazedoxifeno como modulador del receptor de estrogeno selectivo

Country Status (16)

Country Link
US (2) US7504394B2 (es)
EP (1) EP1732888A1 (es)
JP (1) JP2007532556A (es)
KR (1) KR20060134146A (es)
CN (1) CN1946689A (es)
AU (1) AU2005233128A1 (es)
BR (1) BRPI0509385A (es)
CA (1) CA2561004A1 (es)
CR (1) CR8616A (es)
EC (1) ECSP066909A (es)
IL (1) IL177957A0 (es)
MX (1) MXPA06011686A (es)
NO (1) NO20065054L (es)
RU (1) RU2006132181A (es)
WO (1) WO2005100315A1 (es)
ZA (1) ZA200608362B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06011686A (es) * 2004-04-08 2006-12-14 Wyeth Corp Ascorbato de bazedoxifeno como modulador del receptor de estrogeno selectivo.
AR054806A1 (es) * 2005-06-29 2007-07-18 Wyeth Corp Formulaciones de estrogenos conjugados y bazedoxifeno
US8374458B2 (en) * 2005-12-21 2013-02-12 Nec Corporation Tone correcting method, tone correcting apparatus, tone correcting program, and image equipment
CZ302358B6 (cs) * 2007-07-25 2011-03-30 Zentiva, A. S. Nové soli bazedoxifenu
US8216495B2 (en) * 2008-03-25 2012-07-10 Formac Pharmaceuticals N.V. Preparation method for solid dispersions
WO2012007453A1 (en) * 2010-07-14 2012-01-19 Sandoz Ag Crystalline compound of 1-[4-(2-azepan-1-ylethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1h-indol-5-ol
US9212172B2 (en) 2010-09-14 2015-12-15 Dr. Reddy's Laboratories Limited Preparation of crystalline bazedoxifene and its salts
CN103845336B (zh) * 2014-03-24 2016-03-09 江苏知原药业有限公司 一种性能优异的乙酸巴多昔芬组合物
CN106198827B (zh) * 2016-08-11 2018-03-27 齐鲁制药有限公司 高效测定醋酸巴多昔芬及其杂质的药物分析方法
CN108218760A (zh) * 2018-02-26 2018-06-29 福建省微生物研究所 一种巴多昔芬l-乳酸盐的晶型
IT201900001923A1 (it) 2019-02-11 2020-08-11 Erregierre Spa Sali di bazedoxifene utili per la preparazione di bazedoxifene acetato
US11246874B1 (en) 2021-04-20 2022-02-15 Oxygen Biotech LLC Treatment of COVID-19

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5332727A (en) 1993-04-29 1994-07-26 Birkmayer U.S.A. Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
US5811120A (en) 1994-03-02 1998-09-22 Eli Lilly And Company Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US5552412A (en) 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
US5919800A (en) 1995-02-28 1999-07-06 Eli Lilly And Company Benzothiophene compounds, intermediates, compositions, and methods
US5510357A (en) 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
TW397821B (en) 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
US5998402A (en) 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US5880137A (en) 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
US5780497A (en) 1996-04-19 1998-07-14 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
DE69707189T2 (de) 1996-04-19 2002-06-20 American Home Prod Östrogene Verbindungen
IL135343A0 (en) 1997-10-15 2001-05-20 American Home Prod Novel aryloxy-alkyl-dialkylamines
US6005102A (en) 1997-10-15 1999-12-21 American Home Products Corporation Aryloxy-alkyl-dialkylamines
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
AR029538A1 (es) 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
NZ537051A (en) * 2002-06-13 2007-11-30 Wyeth Corp Use of bazedoxifene in an extended dosage treatment regimen
MXPA06011686A (es) * 2004-04-08 2006-12-14 Wyeth Corp Ascorbato de bazedoxifeno como modulador del receptor de estrogeno selectivo.

Also Published As

Publication number Publication date
EP1732888A1 (en) 2006-12-20
RU2006132181A (ru) 2008-05-20
JP2007532556A (ja) 2007-11-15
CR8616A (es) 2007-03-22
KR20060134146A (ko) 2006-12-27
NO20065054L (no) 2006-11-07
ZA200608362B (en) 2009-09-30
AU2005233128A1 (en) 2005-10-27
IL177957A0 (en) 2006-12-31
CA2561004A1 (en) 2005-10-27
US20090137559A1 (en) 2009-05-28
MXPA06011686A (es) 2006-12-14
US7504394B2 (en) 2009-03-17
US20050227964A1 (en) 2005-10-13
CN1946689A (zh) 2007-04-11
WO2005100315A1 (en) 2005-10-27
BRPI0509385A (pt) 2007-09-18

Similar Documents

Publication Publication Date Title
ECSP066909A (es) Ascorbato de bazedoxifeno como modulador del receptor de estrogeno selectivo
ECSP066912A (es) Formulaciones de dispersiones sólidas de acetato de bazedoxifeno
CR9930A (es) Compuestos
PA8600601A1 (es) Ligandos de receptores de cannabinoides y sus usos
CR20150586A (es) Compuestos triciclicos que contienen nitrogeno como agentes antibactercianos
CL2007002167A1 (es) Compuestos derivados de indol, antagonistas iap; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de cancer.
ECSP088648A (es) Nuevos bencimidazoles 2-sustituidos como moduladores de receptor de androgeno selectivos (sarms)
PA8638701A1 (es) Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
ECSP067121A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
CR8615A (es) Polimorfo cristalino de un acetato de bazedoxifeno
CU20090202A7 (es) Compuestos 1,3-diona bicíclicos herbicidamente activos
ECSP067120A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
GT201300164A (es) Derivados de biciclo (3.2.1.) octilamida y sus usos
TW200715634A (en) Stable organic devices
CR9786A (es) Compuestos de bencimidazol-tiofeno
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
DE602007004999D1 (de) 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen-derivate als orexinrezeptor-antagonisten
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
MX2010001093A (es) Herbicidas novedosos.
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
DE602005013935D1 (de) Anionische hydrogelmatrizes mit ph-abhängiger modifizerter wirkstofffreisetzung als arzneimittelträger
PA8646301A1 (es) Inhibidores de la adenilato ciclasa soluble
ATE473968T1 (de) Cycloalkylidinverbindungen als selektive modulatoren des östrogenrezeptors